{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:19:49Z","timestamp":1791937189237,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd005451.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000}}],"reference-count":117,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005451.pub3","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T14:31:50Z","timestamp":1397140310000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Carbamazepine for chronic neuropathic pain and fibromyalgia in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eija A","family":"Kalso","sequence":"additional","affiliation":[{"name":"University of Helsinki; Institute of Clinical Medicine; Helsinki Finland"},{"name":"Helsinki University and Helsinki University Hospital; Department of Anaesthesia, Intensive Care and Pain Medicine; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"key":"10.1002\/14651858.CD005451.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp.29.3.265","article-title":"Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia","volume":"29","author":"Campbell","year":"1966","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005451.pub3-BIB0002|cit2","first-page":"525","article-title":"Nortriptyline-Fluphenazine vs Carbamazepine in the symptomatic treatment of diabetic neuropathy","volume":"27","author":"Gomez-Perez","year":"1996","journal-title":"Archives of Medical Research"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0003|cit3","first-page":"321","article-title":"Effects of Venlafaxine and Carbamazepine for painful peripheral diabetic neuropathy: A randomized double blind and double dummy controlled multicenter trial","volume":"6","author":"Jia","year":"2006","journal-title":"Chinese Journal of Evidence Based Medicine"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1968.00480020015001","article-title":"Carbamazepine in the treatment of neuralgia. Use and side effects","volume":"19","author":"Killian","year":"1968","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archneur.1989.00520450030015","article-title":"Pimozide therapy for trigeminal neuralgia","volume":"46","author":"Lechin","year":"1989","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0006|cit6","first-page":"102","article-title":"A controlled trial of amitriptyline and carbamazepine in central post stroke pain","volume":"77 (Suppl 116)","author":"Leijon","year":"1988","journal-title":"Acta Nuerologica Scandanavica"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3959(89)90108-5","article-title":"Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine","volume":"36","author":"Leijon","year":"1989","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(87)91058-X","article-title":"The analgesic effect of tocainide in trigeminal neuralgia","volume":"28","author":"Lindstrom","year":"1987","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1526-4610.1969.hed0901054.x","article-title":"A four year double blind study of tegretol in facial pain","volume":"9","author":"Nicol","year":"1969","journal-title":"Headache"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01212087","article-title":"Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study","volume":"5","author":"Rull","year":"1969","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0011|cit11","first-page":"869","article-title":"Tegretol in the Treatment of Diabetic Neuropathy","volume":"48","author":"Wilton","year":"1974","journal-title":"S-A Mediese Tydskrif"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-79-6-844","article-title":"Carbamazepine","volume":"79","author":"Crill","year":"1973","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0013|cit13","first-page":"176","article-title":"The management of chronic pain at spinal cord injured patients","volume":"9","author":"Erzurumlu","year":"1996","journal-title":"Romatoloji ve Tibbi Rehabilitasyon Derg"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0014|cit14","first-page":"104","article-title":"Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia","volume":"53","author":"Gerson","year":"1977","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1213\/00000539-200102000-00039","article-title":"The Response of Neuropathic Pain and Pain in ComplexRegional Pain Syndrome I to Carbamazepine andSustained-Release Morphine in Patients Pretreated withSpinal Cord Stimulation: A Double-BlindedRandomized Study","volume":"92","author":"Harke","year":"2001","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1980.tb07654.x","article-title":"Do corticosteroids prevent post-herpetic neuralgia?","volume":"102","author":"Keczkes","year":"1980","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002508-199803000-00009","article-title":"Effect of carbamazepine on pain scores of unipolar depressed patients with chronic pain. A trial of Off-On-Off-On design","volume":"14","author":"Kudoh","year":"1998","journal-title":"The Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1526-4610.1969.hed0901064.x","article-title":"A long term low dosage study of carbamazepine in trigeminal neuralgia","volume":"9","author":"Lloyd-Smith","year":"1969","journal-title":"Headache"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0404.1970.tb05803.x","article-title":"Facial pain treated with carbamazepin (Tegretol)","volume":"46","author":"Rasmussen","year":"1970","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1966.00470140019003","article-title":"Controlled sequential trials of Carbamazepine in trigeminal neuralgia","volume":"15","author":"Rockliff","year":"1966","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD005451.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/PHM.0b013e3182643c85","article-title":"Efficacy of early treatment with carbamazepine in prevention of neuropathic pain in patients with spinal cord injury","volume":"91","author":"Salinas","year":"2012","journal-title":"American Journal of Physical Medicine and Rehabilitaion"},{"issue":"6","key":"10.1002\/14651858.CD005451.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jcma.2011.04.002","article-title":"Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine","volume":"74","author":"Shaikh","year":"2011","journal-title":"Journal of the Chinese Medical Association"},{"issue":"12","key":"10.1002\/14651858.CD005451.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2044.1981.tb08701.x","article-title":"Anticonvulsant drugs used in the treatment of lancinating pain","volume":"36","author":"Swerdlow","year":"1981","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002826-198403000-00003","article-title":"Anticonvulsant drugs and chronic pain","volume":"7","author":"Swerdlow","year":"1984","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1468-2982.1986.0603181.x","article-title":"Tizanidine in the management of trigeminal neuralgia","volume":"6","author":"Vilming","year":"1986","journal-title":"Cephalalgia"},{"issue":"11-12","key":"10.1002\/14651858.CD005451.pub3-BIB0026|cit26","first-page":"627","article-title":"A clinical trial of carbamazepine in the symptomatic treatment of diabetic peripheral neuropathy","volume":"58","author":"Badran","year":"1975","journal-title":"The Journal of the Egyptian Medical Association"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0027|cit27","first-page":"S5","article-title":"Results of a double blind trial comparing oxcarbazepine vs carbamazepine in newly diagnosed, untreated patients with trigeminal neuralgia","volume":"187","author":"Liebel","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD005451.pub3-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S0028-3908(99)00058-1","article-title":"Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists","volume":"38","author":"Ambr\u00f3sio","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0029|cit29","unstructured":"PaPaS author and referee guidance http:\/\/papas.cochrane.org\/papas-documents (accessed 1 August 2013)"},{"issue":"5","key":"10.1002\/14651858.CD005451.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009485.pub2","article-title":"Phenytoin for neuropathic pain and fibromyalgia in adults","author":"Birse","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330903427969","article-title":"Genetic predisposition of life-threatening antiepileptic-induced skin reactions","volume":"9","author":"Chung","year":"2010","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/sim.4780080408","article-title":"How study design affects outcomes in comparisons of therapy","volume":"8","author":"Colditz","year":"1989","journal-title":"Statistical Methods in Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD005451.pub3-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009486.pub2","article-title":"Clonazepam for neuropathic pain and fibromyalgia in adults","author":"Corrigan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6970","key":"10.1002\/14651858.CD005451.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/bmj.309.6970.1677","article-title":"The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?","volume":"309","author":"Counsell","year":"1994","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD005451.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub3","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0039|cit39","volume-title":"Assessing the Effects of Health Technologies","author":"Advisory Group on Health Technology Assessment","year":"1992"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"The Journal of Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jama.1993.03510040124050","article-title":"Three battles to watch in the 1990s","volume":"270","author":"Eddy","year":"1993","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"issue":"10","key":"10.1002\/14651858.CD005451.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009183.pub2","article-title":"Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults","author":"Gill","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0045|cit45","article-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2296-14-28","article-title":"An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population","volume":"14","author":"Hall","year":"2013","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009318.pub2","article-title":"Lacosamide for neuropathic pain and fibromyalgia in adults","author":"Hearn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005451.pub3-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00228-006-0104-4","article-title":"The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose","volume":"62","author":"Herman","year":"2006","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0051|cit51","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status 3 and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0053|cit53","volume-title":"Meta-analysis of randomised clinical trials in pain relief [DPhil thesis]","author":"Jadad-Bechara","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004846.pub2","article-title":"Topical lidocaine for the treatment of postherpetic neuralgia","author":"Khaliq","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005451.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD005451.pub3-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain\uff0ddifferences and similarities: a comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","article-title":"HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain","volume":"12","author":"Kulkantrakorn K. Tassaneeyakul W. Tiamkao S. Jantararoungtong T. Prabmechai N. Vannaprasaht","year":"2012","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005451.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub2","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0064|cit64","first-page":"9","article-title":"The epidemiology of self-reported fibromyalgia in Canada","volume":"27","author":"McNally","year":"2006","journal-title":"Chronic Diseases in Canada"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0065|cit65","article-title":"Chronic Pain","volume-title":"Health Care Needs Assessment","author":"McQuay","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian journal of dermatology, venereology and leprology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005451.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.neuroimage.2007.03.054","article-title":"Brain imaging of neuropathic pain","volume":"37","author":"Moisset","year":"2007","journal-title":"Neuroimaging"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything\uff0dlarge amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"7128","key":"10.1002\/14651858.CD005451.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.316.7128.333","article-title":"Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs","volume":"316","author":"Moore","year":"1998","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.pain.2005.05.001","article-title":"Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results","volume":"116","author":"Moore","year":"2005","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"R644","DOI":"10.1186\/ar1704","article-title":"Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"April 12","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"Online","author":"Moore","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: An approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"Sept 10","author":"Moore","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\u2018\u2018Evidence\u201d in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD005451.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"March 6","author":"Moore","year":"2013","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD005451.pub3-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs\uff0d'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0086|cit86","first-page":"491","article-title":"Mechanism of action of anticonvulsants as analgesic drugs","volume-title":"Wall & Melzack's Textbook of Pain","author":"Morisset","year":"2013"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0087|cit87","unstructured":"Neuropathic pain - pharmacological management NICE clinical guideline 173 November 2013"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"11","key":"10.1002\/14651858.CD005451.pub3-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0091|cit91","first-page":"436","article-title":"Drugs effective in the therapy of the epilepsies","volume-title":"The pharmacological basis of therapeutics","author":"Rall","year":"1992"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0093|cit93","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0197-2456(94)90106-6","article-title":"Failure to conceal treatment allocation schedules in trials influences estimates of treatment effects","volume":"15","author":"Schulz","year":"1994","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1002\/art.37962","article-title":"Neuropathic features of joint pain: a community-based study","volume":"April 1","author":"Soni","year":"2013","journal-title":"Arthritis & Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD005451.pub3-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD005451.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/rheumatology\/kep432","article-title":"Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports","volume":"49","author":"Straube","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0099|cit99","first-page":"353","volume-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2005"},{"issue":"5","key":"10.1002\/14651858.CD005451.pub3-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"issue":"663","key":"10.1002\/14651858.CD005451.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","article-title":"Long-term treatment of trigeminal neuralgia with carbamazepine","volume":"57","author":"Taylor","year":"1981","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD005451.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin: results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"18","key":"10.1002\/14651858.CD005451.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"20","key":"10.1002\/14651858.CD005451.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research","volume":"271","author":"Turner","year":"1994","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD005451.pub3-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD005451.pub3-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub4","article-title":"Lamotrigine for chronic neuropathic pain and fibromyalgia in adults","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD005451.pub3-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008314.pub3","article-title":"Topiramate for neuropathic pain and fibromyalgia in adults","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain, aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007963.pub2","article-title":"Oxcarbazepine for neuropathic pain","author":"Zhou","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005451.pub3-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"key":"10.1002\/14651858.CD005451.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0114|cit114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001133","article-title":"Anticonvulsantdrugs for acute and chronic pain","author":"Wiffen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0115|cit115","article-title":"Anticonvulsantdrugs for acute and chronic pain","author":"Wiffen","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005451.pub3-BIB0116|cit116","article-title":"Anticonvulsantdrugs for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005451.pub3-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub2","article-title":"Carbamazepine for acute and chronic pain in adults","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005451.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T10:04:04Z","timestamp":1666692244000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005451.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":117,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005451.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,10]]}}}